ETCAMAH
Live / Allowed — Notice of allowance issued (as of 23 Sept 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 29 May 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99208291
- Mark type
- Stylized text
- Filed
- 29 May 2025
- Published for opposition
- 29 Jul 2025
- Attorney of record
- Cara M. Kearney
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal, and immune systems; Vaccines; Pharmaceutical preparations for the treatment of infection, inflammation, hematological, and autoimmune related diseases and disorders; Antibodies for medical purposes; Pharmaceutical preparations for use in oncology
Owner
- AstraZeneca AB, Sodertalje, SE
- AstraZeneca AB, Sodertalje, SE
Prosecution history
- 13 Jan 2026 — TEAS DELETE 1(B) BASIS RECEIVED
- 23 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 29 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Jul 2025 — PUBLISHED FOR OPPOSITION
- 23 Jul 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Jun 2025 — ASSIGNED TO EXAMINER
- 29 May 2025 — APPLICATION FILING RECEIPT MAILED
- 29 May 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 29 May 2025 — NEW APPLICATION ENTERED